Other headlines: Cardiac cath usage declinesViztek launches mammo PACS viewer
An ultrasound scanner so small it fits in the palm of your hand will soon enter the U.S. market from industry newcomer Signostics. The Australian firm has gotten the go-ahead from the FDA to market the "personal ultrasound" scanner, which the company plans to package as a cost-effective device for individual health professionals to use in their clinical practices. The scanner weighs about half a pound and will be priced at a fraction of the cost of cart-based systems, according to the firm. Primary targets are emergency medicine, primary care, remote healthcare, critical care, pediatrics, musculoskeletal, palliative care, and sports medicine. Signostics will tout applications including assessment of trauma patients and abdominal aortic aneurysm screening, as well as basic obstetric exams, such as pregnancy viability and fetal positioning. Physician-engineer Dr. Neil Bartlett founded Signostics in Adelaide, Australia, in January 2005, later establishing a U.S. office in Palo Alto, CA. The company has raised about $8 million from angel investors, Australian government grant providers, and Playford Capital. Another $4 million is expected to close shortly.
The number of cases handled in cath labs is going down, according to a recent survey performed by IMV, a market research firm in Des Plaines, IL. These labs had shown steady growth, but the pattern changed direction abruptly in 2007, falling about 10% that year and another 1% the next. IMV linked the decline to the advent of CT coronary angiography, but noted that other factors may be involved. These include a controversy over the use of drug-eluting stents that developed around 2005-2006, which may have reduced the number of therapeutic coronary cases, and increased use of pre-authorization policies by third-party insurers.
A new full-featured mammography viewer from Viztek will be marketed to work with the company's Opal-RAD PACS, as well as any other PACS supporting DICOM query/retrieve for mammography. The viewer, which is configurable for simultaneous gray scale and color, can display breast images from full-field digital mammography systems, computed radiography, and MR. Major computer-aided detection systems can be launched from the viewer toolbar.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.
Computed Tomography Study Assesses Model for Predicting Recurrence of Non-Small Cell Lung Cancer
January 31st 2025A predictive model for non-small cell lung cancer (NSCLC) recurrence, based on clinical parameters and CT findings, demonstrated an 85.2 percent AUC and 83.3 percent sensitivity rate, according to external validation testing in a new study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.